I am very excited to attend this PharmStars Innovation Summit on May 11th. See you there!
610
5 months ago
LinkedIn Content Strategy & Writing Style
Unknown
1 person tracking this creator on ViralBrain
This creator positions themselves as a high-stakes biotech strategist who bridges the lethal gap between laboratory science and pharmaceutical commercialization. Their content strategy centers on "post-mortem" narratives of failed deals, using recurring themes of manufacturing economics, patient identification, and portfolio volatility to expose the blind spots of technical founders. They are notable for their unsentimental focus on commercial viability, arguing that clinical success is irrelevant if the "cost of goods" or "diagnosed patient" data doesn't survive a corporate committee. By intersecting deep-tech empathy with cold-eyed BD diligence, they offer a rare value proposition: teaching scientists how to build programs that are not just medically sound, but "deal-proof" against shifting corporate priorities.
0
I am very excited to attend this PharmStars Innovation Summit on May 11th. See you there!
A rare disease patient waits 5 years for a diagnosis, then finds out nobody’s building a drug for them. Harvard Medical School and Boston Children’s just published WEST, an AI model that reads messy…
A gene therapy founder's CSO couldn't answer one question. It killed a deal the science should have won. The founder had already cleared the BD team. Early data looked promising. Orphan designatio…
A rare disease founder spent four months celebrating an FDA tailwind. He never built the thing pharma's commercial team actually asks about. Here's what happened. The FDA's new guidance dropped. He…
On Any Given Tuesday A scientist spent twenty years developing a gene therapy for children going blind. The preclinical data was strong. The clinical trial was ready to go. The pharmaceutical compan…
A rare disease patient waits 5 years for a diagnosis, then finds out nobody’s building a drug for them. Harvard Medical School and Boston Children’s just published WEST, an AI model that reads messy…
Free tools to help you write, score, and benchmark in the same style.
Other creators worth studying alongside Unknown.
Simon Sinek
Optimist, New York Times bestselling author of "Start with Why" and "The Infinite Game", and founder of The Optimism Company
6 Viral Score
Mike Taylor
CEO & Co-Founder at AskRally.com – virtual focus groups.
14 Viral Score
Mahmud Hasan
Helping people with automate their business and service | App Developer
56 Viral Score
Kunal Shah
ViralBrain plans, writes, and schedules your LinkedIn content, using official LinkedIn APIs so your account stays safe.
Write like Unknown.